Kodiak Sciences Inc. (KOD) vs Ligand Pharmaceuticals Incorporated (LGND)
A side-by-side comparison of Kodiak Sciences Inc. and Ligand Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KOD
Kodiak Sciences Inc.
$92.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LGND
Ligand Pharmaceuticals Incorporated
$296.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KOD vs LGND
growth of $100 · dividends reinvested · last 8yKOD +4521.2% (+61.5%/yr)LGND +93.4% (+8.6%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
KOD LGND
KOD vs LGND: by the numbers
- •LGND is the larger company ($5.95B vs $5.78B market cap).
- •LGND is profitable (67.88% net margin) while KOD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KOD | LGND |
|---|---|---|
| P/E ratio | N/A | 31.76 |
| Forward P/E | N/A | 31.91 |
| P/S ratio | N/A | 20.48 |
| P/B ratio | 94.58 | 6.15 |
| EV / EBITDA | N/A | 45.02 |
| FCF yield | N/A | 2.21% |
Profitability
| Metric | KOD | LGND |
|---|---|---|
| Gross margin | 0.00% | 98.58% |
| Operating margin | 0.00% | 17.61% |
| Net margin | 0.00% | 67.88% |
| ROE | -396.09% | 20.38% |
| ROIC | -115.23% | 3.91% |
Growth (annualized)
| Metric | KOD | LGND |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.92% |
| FCF CAGR (5Y) | N/A | -0.49% |
| Total return CAGR (5Y) | 36.19% | 30.72% |
Frequently asked
- Is KOD or LGND more profitable?
- LGND runs the higher net margin — KOD at 0.00% versus LGND at 67.88%.
- How have KOD and LGND total returns compared?
- Over the past 5 years, KOD delivered 36.19% and LGND delivered 30.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ligand Pharmaceuticals P/E ratioKodiak Sciences ROELigand Pharmaceuticals ROEKodiak Sciences operating marginLigand Pharmaceuticals operating marginKodiak Sciences revenue growthLigand Pharmaceuticals revenue growthKodiak Sciences free cash flowLigand Pharmaceuticals free cash flow
Kodiak Sciences & Ligand Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.